CAGR: 7.10%Current Market Size: USD 4.80 BillionFastest Growing Region: APAC
Largest Market: North AmericaProjection Time: 2023-2030Base Year: 2022
The global joint pain injection market is expected to grow from USD 4.80 billion in 2022 to USD 8.30 billion by 2030, at a CAGR of 7.10% during the Projection period 2023-2030. The growing prevalence of osteoarthritis mainly drives the growth of the joint pain injection market.
An injury to any of the tendons, bursae, or ligaments surrounding the joint may result in discomfort. Joint pain injections are drugs injected directly into the joints to help the patient feel less inflamed and uncomfortable. Joint pain injections, often referred to as intra-articular injections, are frequently used to treat inflammatory joint illnesses such as psoriatic arthritis, rheumatoid arthritis, bursitis, osteoarthritis, gout, and other types of joint pain. Joint pain, stiffness, redness, and a decline in physical activity are some signs of arthritis. The two most common varieties of arthritis are rheumatoid arthritis, an inflammatory condition that primarily affects the hands and feet, and osteoarthritis, a degenerative joint disease. Age, increasing obesity rates, a lack of physical exercise, and bone mineral density decrease are all risk factors for osteoarthritis. Corticosteroid and hyaluronic acid injections are frequently utilized to reduce swelling and discomfort in affected joint areas. Joint pain injections are given directly into the joints to ease discomfort and reduce swelling and inflammation. The majority of the time, pre-existing illnesses or disorders in the elderly population are the cause of joint discomfort. Arthritis is a widespread condition that primarily affects the spine's knee, ankle, hip, shoulder, elbow, and facet joints. It causes joint pain, which causes inflammation and adds to joint discomfort. Additionally, during the joint pain injections market Projection, there is predicted to be a rise in the prevalence of osteoarthritis and rheumatoid arthritis and a corresponding rise in the demand for cheap therapies for these disorders.
Sample Request: - Global Joint Pain Injection Market
Market Dynamics:
Drivers:
The rising geriatric population and sedentary lifestyle in industrialized and developing nations are just two factors contributing to the increased frequency of musculoskeletal illnesses like osteoarthritis. For instance, the World Health Organization (WHO) projects that in 2020, 1.71 billion individuals will be affected by musculoskeletal illnesses globally. Additionally, according to Healio estimates, 303.1 million people worldwide had osteoarthritis in 2018. As a result, there is a sizable patient population with osteoarthritis and increased awareness of the importance of early detection and treatment, driving demand for pain relief products like injections for joint pain. Rising healthcare per capita costs in industrialized nations and new product releases by market participants also increase the demand for intra-articular injections.
Restraints:
The rising incidence of musculoskeletal disorders and the spike in demand for efficient treatment drives joint pain injection demand. Additionally, it is believed that the expensive cost of joint injections and strict product approval rules will limit market expansion. For instance, the U.S. FDA denied the approval of tanezumab for the treatment of osteoarthritis pain in March 2021 because to some risk-benefit concerns. Although clinical data indicated that tanezumab could help patients with OA pain, the FDA's Arthritis Advisory Committee (AAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM) decided that, even with the proposed modification efforts, the associated risk for joint destruction, rapidly progressing osteoarthritis, and other safety outcomes were more significant.
Opportunities:
The aging population and the prevalence of arthritis increase the need for efficient joint pain treatment solutions. The development of cutting-edge treatment options, including platelet-rich plasma injections and plasma matrix therapy, is being done by major participants in the joint pain injections market. The adoption of innovative products is aided by continuing research projects emphasizing novel treatments' advantages. For instance, according to the National Library of Medicine, the anti-inflammatory effect of platelet-rich plasma therapy for joint pain linked with osteoarthritis dramatically decreased discomfort.
Challenges:
Intra-articular injections are less frequently used in underdeveloped nations to alleviate joint pain because of a lack of knowledge about these items. Furthermore, the market's expansion is being constrained by the absence of reimbursement policies for intra-articular injections in these nations.
Segmentation Analysis:
The global joint pain injection market has been segmented based on injection type, end-user, and region.
By Injection Type
The injection type segment is an hyaluronic acid injections, corticosteroid injections, platelets rich plasma injections, and others. The hylauric acid injections segment led the largest share of the joint pain injection market with a market share of around 35.6% in 2022. Patients with osteoarthritis (OA)-related knee discomfort who have already tried ineffective treatments like acetaminophen and other opioids can benefit from hyaluronic acid injections. As a non-surgical treatment option, hyaluronic acid injections have grown in favour, especially given how reluctant clinicians are to regularly administer intraarticular corticosteroid injections. The market participants are putting a lot of effort into creating new products with plenty of benefits and often releasing new products. For instance, through TCM Biotech International Corp. in August 2021, Seikagaku Corporation introduced HyLink, an intra-articular single-injection Visco supplement for the treatment of knee osteoarthritis, in Taiwan. Using cross-linking technology, a hyaluronate hydrogel serves as the major component. Over the Projection period, it is anticipated that the launches will accelerate segment growth.
By Joint Type
The joint type segment is shoulder & elbow, knee & ankle and others. The knee & ankle segment led the largest share of the joint pain injection market with a market share of around 41% in 2022. With the increasing prevalence of knee osteoarthritis, the demand for intra-articular injections for managing knee pain is expected to increase in the near future. As a result of the strin product portfolio offered by key players for the treatment of knee osteoarthritis pain as well as the growing number of patients undergoing treatment, the market is expected to grow.
By End-User
The end-user segment is retail pharmacies, online pharmacies, hospitals pharmacies, and others. The online pharmacies segment led the largest share of the joint pain injection market with a market share of around 46% in 2022. The expansion of the segment is being driven by the increased internet penetration in emerging nations. Additionally, the trend of digitalization has greatly aided the expansion of the online pharmacy market.
Global Joint Pain Injection Market - Sales Analysis.
The sale of the joint pain injection market expanded at a CAGR of 6.3% from 2016 to 2022.
Rising rates of joint pain in developed and developing countries, as well as the quick development of injections that let doctors identify the primary sources of pain and help reduce it quickly, are expected to have an impact on the market's expansion. The muscles, ligaments, and articular capsules are numbed by the anaesthetic medication that is part of the facet joint injections. One of the main factors boosting the output of facet joint injections during the anticipated timeframe has been recognised as rising demand for non-surgical therapy. Additionally, it is anticipated to contribute to the overall facet joint injection build-up during the Projection period, boosting the focus on efficient pain management.
According to the Arthritis Foundation, arthritis is the leading cause of adult disability in the United States. In the US, 300,000 babies and toddlers and 54 million adults have arthritis or another rheumatic condition. In the US, 78 million people would have been given an arthritis diagnosis by 2040. Additionally, approximately 31 million Americans suffer from osteoarthritis, the most prevalent form of arthritis. The market for joint pain injections is anticipated to grow due to the rising prevalence of arthritis and the increased need for disease-modifying therapies. Obesity is associated with a number of joint issues, especially those that impact the knee, such as osteoarthritis and knee pain.
Thus, owing to the aforementioned factors, the global joint pain injection market is expected to grow at a CAGR of 7.10% during the Projection period from 2023 to 2030.
By Regional Analysis:
The regions analyzed for the joint pain injection market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. North America region dominated the joint pain injection market and held a 38.9% share of the market revenue in 2022.
Global Joint Pain Injection Market - Country Analysis:
Germany's joint pain injection market size was valued at USD 0.10 billion in 2022 and is expected to reach USD 0.18 billion by 2030, at a CAGR of 8% from 2023 to 2030. Due to its huge patient population, Germany held the top spot in the regional market for joint pain in 2021. The increased demand for osteoarthritis therapies will lead to a large increase in the use of hyaluronic acid in Germany.
China’s joint pain injection market size was valued at USD 0.37 billion in 2022 and is expected to reach USD 0.69 billion by 2030, at a CAGR of 8.2% from 2023 to 2030. Due to the widespread musculoskeletal conditions that lead to joint discomfort. Growing public awareness of non-invasive orthopaedic therapies, ongoing implant technology advancements, and cutting-edge medical facilities.
India's joint pain injection market size was valued at USD 0.28 billion in 2022 and is expected to reach USD 0.52 billion by 2030, at a CAGR of 8.1% from 2023 to 2030. Due to India's enormous patient base, growing treatment uptake, rise in the geriatric population, and increased awareness of joint-related illnesses.
Key Industry Players Analysis:
To increase their market position in the global joint pain injection market business, top companies focus on tactics such as adopting new technology, mergers & acquisitions, product developments, collaborations, partnerships, joint ventures, etc.
Latest Development:
Report Metrics
Report Attribute |
Details |
Study Period |
2022-2030 |
Base year |
2022 |
CAGR (%) |
7.10% |
Market Size |
4.80 billion in 2022 |
Projection period |
2023-2030 |
Projection unit |
Value (USD) |
Segments covered |
By Injection Type, By Joint Type, By End-User, and By Region. |
Report Scope |
Revenue Projection, competitive landscape, company ranking, growth factors, and trends |
Companies covered |
Anika Therapeutics Inc., Ferring Pharmaceuticals Inc., Bioventus, Zimmer Biomet Holdings Inc., Sanofi, Allergen Plc., Pfizer Inc., Chugai Pharmaceutical Co. Ltd, SEIKAGAKU Corporation, and Ferring B.V. |
By Injection Type |
|
By Joint Type |
|
By End-User |
|
Regional scope |
|
Scope of the Report
Global Joint Pain Injection Market By Injection Type:
Global Joint Pain Injection Market By Joint Type:
Global Joint Pain Injection Market By End-User:
Global Joint Pain Injection Market By Region:
Global joint pain injection market is expected to reach USD 8.30 billion by 2030.
The joint pain injection market is projected to have a CAGR of 7.10%.
Based on the injection type, the joint pain injection market is segmented into hyaluronic acid injections, corticosteroid injections, platelets-rich plasma injections, and others.
Leading market players active in the global joint pain injection market are Pfizer Inc, Flexion Therapeutics, Inc, Zimmer Biomet Holdings Inc, SEIKAGAKU CORPORATION, Allergan Plc, Anika Therapeutics, Inc, Bioventus LLC, Ferring B.V, Chugai Pharmaceutical Co., Ltd, and Sanofi S.A. among other.
Based on the end-user, the global joint pain injection market has been segmented into retail pharmacies, online pharmacies, hospitals pharmacies, and others.
Political Factors- the level of political stability the country has recently experienced. the integrity of the politicians and their susceptibility for corrupt behaviour, as the consequences might lead to high-ranking government officials resigning or being impeached. The laws that the country upholds, especially those that are concerned with trade, like contract law, because they define what is and is not allowed to do For instance, some countries prohibit alcohol or have strict regulations that must be followed, while other governments have bloated bureaucracies that discourage business.
Economic Factors- Whether the market is now organised as a monopoly, oligopoly, or anything more akin to a system of perfect competition. Depending on the country's GDP growth rate, will likely expand in the near future at a varying pace. The amount that people are willing to invest and borrow is influenced by the country's interest rates. Higher rates would encourage more investment, which would boost GDP. How well the financial markets function also affects how well one may raise cash at a fair price, taking demand and supply into account. The country's exchange rate would have an effect on profitability, particularly if it engaged in international trade.
Social Factors- Whether or whether a certain product may be sold to a particular demographic depends significantly on the age and gender distribution of the population. Because makeup is marketed mostly to women, selecting a demographic that is predominately male would result in fewer people being reached than targeting a group that is predominately female. It would be hard to promote a premium product to the broader public if the majority of individuals belonged to a lower class; instead, they would have to concentrate on extremely specialised niche markets. Therefore, the distribution of classes throughout the population is vital. Due to the disparity in educational backgrounds between marketers and the target market, it may be difficult to effectively relate to and attract the target market.
Technological Factors- opponents' aforementioned technological discoveries and advancements. The degree of adoption of a new technology, as well as how quickly it is developing and displacing sales from competitors in the business in question, must all be closely monitored. This would be the level of urgency required to effectively react to the creation, either by matching the technology or developing a unique replacement. The profitability that results could be greatly increased or decreased depending on how technology affects the costs that the majority of enterprises in the sector must bear.
Environmental Factors- The ability to move materials and the finished product may be significantly impacted by the weather at this time. In the event of, say, an unexpected monsoon, this would then affect when the finished product would be delivered. Climate change would cause some goods to lose all of their value. In the case of textiles, warm winter gear has a substantially smaller market in countries where the winter has become quite mild as a result of global warming. Laws may require businesses with high rubbish production to govern their environmental practises.
Legal Factors- As was already stated, the goal of intellectual property laws and other data protection legislation is to protect the ideas and patents of companies who solely profit from the information. The system will lose its competitive edge and is very likely to fail if there is a risk of data theft. Anti-discrimination rules passed by the government are meant to protect employees and ensure that everyone is treated fairly and given the same opportunities, regardless of gender, age, handicap, race, religion, or sexual orientation. Health and safety laws were formed as a result of witnessing the horrifying conditions that people had to work in during and immediately after the industrial revolution.
List of Table
List of Figures